By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1-3 Burtonhole Lane, Mill Hill

London    NW7 1AD  United Kingdom
Phone: 44-0-20-8906-7100 Fax: n/a



Drug Discovery

Company News
Heptares Hosts Scientific Symposium In Celebration Of 10-year Anniversary 7/13/2017 8:14:50 AM
Heptares And Peptidream Enter Strategic Collaboration To Discover, Develop And Commercialise Novel Therapeutics In Inflammatory Disease 6/29/2017 8:46:44 AM
Heptares Enters a New Research And Drug Discovery Collaboration Under Its "Orbit" Initiative With New York University School Of Medicine 6/28/2017 7:51:12 AM
Heptares Plans Relocation To Cambridge, UK 6/20/2017 9:00:36 AM
Heptares Solves First Full-Length Structure Of GLP-1 Receptor Bound To Peptide Agonist 6/1/2017 9:08:36 AM
Heptares’ Co-Founder And Chief Scientific Officer, Fiona Marshall, Receives 2017 John Daly Lecture Award In Recognition Of Her Outstanding Contribution To GPCR Drug Discovery 5/18/2017 12:57:02 PM
Heptares To Receive U.S.$5 Million Milestone Payment From Teva (TEVA) 5/18/2017 9:50:49 AM
Heptares Collaboration With AstraZeneca PLC (AZN) Yields New Insights To Advance Drug Discovery In Pain, Cancer And Inflammation 4/27/2017 6:49:09 AM
Sosei Subsidiary Heptares To Receive $12 Million Milestone Payment From AstraZeneca PLC (AZN) 4/5/2017 8:08:53 AM
Heptares Enters Agreement With Daiichi Sankyo To Discover And Develop Novel, Small-Molecules For The Treatment Of Pain 3/13/2017 6:47:57 AM